Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor

相似書籍

• Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors versus single agent chemotherapy as second‐line treatment for non–small‐cell lung cancer wild‐type or unknown status for EGFR
  由: Créquit, Perrine, et al.
  出版: (2018)
• Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systematic review and network meta-analysis
  由: Créquit, Perrine, et al.
  出版: (2017)
• Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer
  由: Créquit, Perrine, et al.
  出版: (2016)
• Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study
  由: Bafeta, Aïda, et al.
  出版: (2012)
• The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status
  由: Bronte, Giuseppe, et al.
  出版: (2016)